急性心衰治疗若干进展[汇编].pptVIP

Purpose 在常规治疗基础上，通过双盲安慰剂对照研究评价奈西立肽对于急性代偿性心衰患者的疗效和安全性. Double blinded study meaning subjects, MD, and research team are unaware of what treatment is being received. * 精品PPT·值得借鉴 * 精品PPT·值得借鉴 入选标准 静息时呼吸困难 肺淤血 入院24小时内存在心衰的症状和体征 * 精品PPT·值得借鉴 Interventions Randomized to 1 of 2 Groups N=7141 Nesiritide plus standard of care 首先给予其静脉注射负荷剂量的奈西立肽， 然后持续静脉滴注24 h，共给药7天 Placebo plus standard of care USE OF OPEN LABEL NESIRITIDE IS NOT ALLOWED AT ANY TIME!! * 精品PPT·值得借鉴 Why is this study being done? Does Nesiritide decrease re-hospitalization or death in 30 days? Does Nesiritide decrease symptoms